Bersuker et al. (88) have found that FSP1 had the capacity to mediate ferroptosis resistance in the mouse tumor xenograft, and that the expression of FSP1 was positively related to the resistance to ferroptosis in hundreds of cancer cell lines. Here, AIFM2 is linked to cancer.